Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Bennett, Charles
One or more keywords matched the following items that are connected to Bennett, Charles
Item TypeName
Academic Article G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis.
Concept Granulocyte Colony-Stimulating Factor
Concept Granulocyte-Macrophage Colony-Stimulating Factor
Concept Colony-Stimulating Factors
Academic Article Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease.
Academic Article Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials.
Academic Article Economic analyses of clinical trials in cancer: are they helpful to policy makers?
Academic Article Role of granulocyte-macrophage colony stimulating factor (GM-CSF) after autologous bone marrow transplantation for Hodgkin's disease.
Academic Article Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.
Academic Article Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?
Academic Article Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making?
Academic Article Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer.
Academic Article Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.
Academic Article Acting on imperfect evidence: How much regret are we ready to accept?
Academic Article 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
Academic Article When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective?
Academic Article Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
Academic Article Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Academic Article Myeloid growth factors. Clinical practice guidelines in oncology.
Academic Article Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
Academic Article Myeloid growth factors.
Academic Article Colony-stimulating factors for febrile neutropenia during cancer therapy.
Academic Article Colony-stimulating factors for febrile neutropenia.
Academic Article Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis.
Academic Article Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490).
Academic Article Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.
Academic Article The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology.
Academic Article Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials.
Academic Article Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
Academic Article 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel.
Search Criteria
  • Granulocyte
  • Colony Stimulating Factor